Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 12:58 AM
Ignite Modification Date: 2025-12-25 @ 12:58 AM
NCT ID: NCT01640093
Eligibility Criteria: Inclusion Criteria: * Have body weight not less than 50 kg * Must be a non-smoker, and has no history of smoking or use of nicotine-containing substances within the previous 2 months * Must have blood pressure between 90 and 140 mmHg systolic, inclusive, and no higher than 90 mmHg diastolic * Must have a 12-lead electrocardiogram consistent with normal cardiac conduction and function * Must agree to use an adequate contraception method as deemed appropriate by the investigator and to not donate sperm during the study for 3 months after receiving the last dose of study medication Exclusion Criteria: * History of or current clinically significant medical illness including cardiac arrhythmias or other cardiac disease that could interfere with the interpretation of the study results * Clinically significant abnormal values for hematology or urinalysis (at screening) * Clinically significant abnormal physical examination vital signs or 12-lead electrocardiogram (at screening) * Usage of any prescription or nonprescription medication, except for acetaminophen, and oral contraceptives and hormonal replacement therapy within 14 days before the first dose of the study medication is scheduled * Unable to swallow solid, oral dosage forms whole with the aid of water (participants may not chew, divide, dissolve, or crush the study medication)
Healthy Volunteers: True
Sex: MALE
Minimum Age: 18 Years
Maximum Age: 55 Years
Study: NCT01640093
Study Brief:
Protocol Section: NCT01640093